Mammary Carcinoma, Human
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
|
26124351 |
2015 |
Mammary Carcinoma, Human
|
0.370 |
Biomarker
|
disease |
CTD_human |
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
|
26124351 |
2015 |
Mammary Carcinoma, Human
|
0.370 |
Biomarker
|
disease |
CTD_human |
CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models.
|
25221644 |
2014 |
Mammary Carcinoma, Human
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Molecular profiling of single circulating tumor cells with diagnostic intention.
|
25358515 |
2014 |
Mammary Carcinoma, Human
|
0.370 |
Therapeutic
|
disease |
CTD_human |
CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models.
|
25221644 |
2014 |
Mammary Carcinoma, Human
|
0.370 |
Biomarker
|
disease |
CTD_human |
Molecular profiling of single circulating tumor cells with diagnostic intention.
|
25358515 |
2014 |
Mammary Carcinoma, Human
|
0.370 |
Therapeutic
|
disease |
CTD_human |
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer.
|
21638049 |
2012 |
Mammary Carcinoma, Human
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.
|
22302033 |
2012 |
Mammary Carcinoma, Human
|
0.370 |
Biomarker
|
disease |
CTD_human |
Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.
|
22302033 |
2012 |
Mammary Carcinoma, Human
|
0.370 |
Biomarker
|
disease |
CTD_human |
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer.
|
21638049 |
2012 |
Mammary Carcinoma, Human
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Suppression of Heregulin-β1/HER2-Modulated Invasive and Aggressive Phenotype of Breast Carcinoma by Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation.
|
19617202 |
2011 |
Mammary Carcinoma, Human
|
0.370 |
Biomarker
|
disease |
CTD_human |
Suppression of Heregulin-β1/HER2-Modulated Invasive and Aggressive Phenotype of Breast Carcinoma by Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation.
|
19617202 |
2011 |
Mammary Carcinoma, Human
|
0.370 |
Biomarker
|
disease |
CTD_human |
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.
|
21501481 |
2011 |
Mammary Carcinoma, Human
|
0.370 |
Biomarker
|
disease |
CTD_human |
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
|
20941507 |
2011 |
Mammary Carcinoma, Human
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.
|
21501481 |
2011 |
Mammary Carcinoma, Human
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
|
20941507 |
2011 |
Mammary Carcinoma, Human
|
0.370 |
Biomarker
|
disease |
CTD_human |
Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level.
|
19896266 |
2010 |
Mammary Carcinoma, Human
|
0.370 |
Biomarker
|
disease |
CTD_human |
Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.
|
20332317 |
2010 |
Mammary Carcinoma, Human
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
|
20197467 |
2010 |
Mammary Carcinoma, Human
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.
|
20332317 |
2010 |
Mammary Carcinoma, Human
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level.
|
19896266 |
2010 |
Mammary Carcinoma, Human
|
0.370 |
Biomarker
|
disease |
CTD_human |
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
|
20197467 |
2010 |
Mammary Carcinoma, Human
|
0.370 |
Biomarker
|
disease |
CTD_human |
Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
|
19801490 |
2009 |
Mammary Carcinoma, Human
|
0.370 |
Therapeutic
|
disease |
CTD_human |
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
|
19436038 |
2009 |
Mammary Carcinoma, Human
|
0.370 |
Biomarker
|
disease |
CTD_human |
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
|
19436038 |
2009 |